De Novo DNM1L Variant in a Teenager With Progressive Paroxysmal Dystonia and Lethal Super-refractory Myoclonic Status Epilepticus

  • Ryan, Conor S. MD
  • Fine, Anthony L. MD
  • Cohen, Alexander L. MD, PhD
  • Schiltz, Brenda M. MD
  • Renaud, Deborah L. MD
  • Wirrell, Elaine C. MD
  • Patterson, Marc C. MD
  • Boczek, Nicole J. PhD
  • Liu, Raymond PhD
  • Babovic-Vuksanovic, Dusica MD
  • Chan, David C. MD, PhD
  • Payne, Eric T. MD
Journal of Child Neurology 33(10):p 651-658, September 2018. | DOI: 10.1177/0883073818778203

Background:

The dynamin 1-like gene (DNM1L) encodes a GTPase that mediates mitochondrial and peroxisomal fission and fusion. We report a new clinical presentation associated with a DNM1L pathogenic variant and review the literature.

Results:

A 13-year-old boy with mild developmental delays and paroxysmal dystonia presented acutely with multifocal myoclonic super-refractory status epilepticus. Despite sustained and aggressive treatment, seizures persisted and care was ultimately withdrawn in the context of extensive global cortical atrophy. Rapid trio-whole exome sequencing revealed a de novo heterozygous c.1207C>T (p.R403C) pathogenic variant in DNM1L. Immunofluorescence staining of fibroblast mitochondria revealed abnormally elongated and tubular morphology.

Conclusions:

This case highlights the diagnostic importance of rapid whole exome sequencing within a critical care setting and reveals the expanding phenotypic spectrum associated with DNM1L variants. This now includes progressive paroxysmal dystonia and adolescent-onset super-refractory myoclonic status epilepticus contributing to strikingly rapid and progressive cortical atrophy and death.

Copyright ©2018Sage Publications
View full text|Download PDF